Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.
about
Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Efficacy and safety of a three ...... on open-label extension study.
@en
Efficacy and safety of a three ...... on open-label extension study.
@nl
type
label
Efficacy and safety of a three ...... on open-label extension study.
@en
Efficacy and safety of a three ...... on open-label extension study.
@nl
prefLabel
Efficacy and safety of a three ...... on open-label extension study.
@en
Efficacy and safety of a three ...... on open-label extension study.
@nl
P2093
P2860
P356
P1476
Efficacy and safety of a three ...... on open-label extension study.
@en
P2093
Alexey Boyko
Krzysztof Selmaj
Mat D Davis
Natalia Ashtamker
Peter Rieckmann
Scott Kolodny
P2860
P304
P356
10.1177/1352458516664033
P577
2016-08-08T00:00:00Z